Projected Earnings Date: 2025-02-06    (Delayed quote data   2025-01-03)
Last
 46.66
Change
 ⇑ +1.62   (+3.60%)
Volume
  708,765
Open
 45.08
High
 46.73
Low
 44.27
8EMA (Daily)
 44.78
40EMA (Daily)
 42.23
50EMA (Daily)
 41.99
STO (Daily)
 82.322
MACD Hist (Daily)
 0.520
8EMA (Weekly)
 43.016
40EMA (Weekly)
 44.83
50EMA (Weekly)
 47.02
STO (Weekly)
 65.777
MACD Hist (Weekly)
 2.003
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com